Stage FocusSeed, Series A, Series B+
GeographyUS, Europe
TypeCVC
Last Activity2025
Industry Focus
Industries
BiotechSemiconductorsAdvanced MaterialsMedtechPhotonicsClimate TechNeurotechHardware
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
M Ventures is the strategic CVC of Merck KGaA (the German Merck, not the US pharmaceutical company), founded in 2009 with a €600M+ fund allocation. The firm has made 195 investments and developed 80+ companies from creation to exit.
The dual focus spans biotechnology (healthcare, life science tools) and technology (semiconductors, display). Portfolio companies include Tignis (AI for semiconductor...
Notable Investments
T
TignisM
MemryXSimilar Funds
Osage University Partners
Bala Cynwyd, United States
DeepTech NativeBiotechMedtechClimate TechSeedSeries A
Parkwalk Advisors
London, United Kingdom
DeepTech NativeBiotechAIQuantumSeedSeries A
Sofinnova Partners
Paris, France
DeepTech NativeBiotechMedtechClimate TechSeedSeries A
Amadeus Capital Partners
Cambridge, United Kingdom
Pure DeepTechQuantumAIBiotechSeedSeries A
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantumSemiconductorsSeedSeries A
Section 32 (S32)
Palo Alto, United States
DeepTech NativeBiotechMedtechAISeedSeries A